Annual Drug Patent Expirations for CLINDESSE
Clindesse is a drug marketed by Padagis Us and is included in one NDA. It is available from one supplier. There are two patents protecting this drug and one Paragraph IV challenge.
Drug patent litigation for CLINDESSE.
This drug has forty-four patent family members in twenty-one countries.
The generic ingredient in CLINDESSE is clindamycin phosphate. One supplier is listed for this compound. Additional details are available on the clindamycin phosphate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
